InvestorsHub Logo
Followers 26
Posts 4884
Boards Moderated 0
Alias Born 01/26/2017

Re: None

Monday, 01/14/2019 2:47:52 PM

Monday, January 14, 2019 2:47:52 PM

Post# of 37236
I think Typenex has a role to play in all this.

In the most recent Schedule 13G filing, John M. Fife owns a 10% of the common shares (though I'm not sure if it's an aggregate amount amongst all the listed subsidiaries, or if it's just 10%. If it's aggregate, it's 40% split among Typenex, Red Cliffs, JFV Holdings, and John himself.)

https://www.otcmarkets.com/filing/html?id=12877862&guid=Wqj8UWGktwzjs3h

Now, the key name here is Typenex. This company offers a wide variety of medical practice products, particular of interest are blood storage and testing.

What's this company have to do with Cirque Energy, a defunct and basically shell company? Why wouldn't John just dump those 34 million shares and move on?

My guess is they are going to pull a reverse merger to bring Typenex to the public market. This is a low float, no convertible debt, very cheap stock right now. It wouldn't take much to buy up a majority of the common shares. It would explain why the transfer agent has been updating regularly over the past couple of months, perhaps the company is trying to bring the past filings up to date and regain that OTCQB status with the SEC?

Edit: Looks like John was invested heavily in Rich Pharmaceuticals Inc (RCHA) back in 2016 as well, around the same time as CRQE. Doesn't look like he is any more, but he's still in here at CRQE. Could be interesting things at play.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.